免疫療法薬市場、規模、シェア、動向、産業分析レポート：タイプ別、用途別、投与経路別、エンドユーザー別、地域別 - 市場予測、2025年～2034年

Polaris Market Research社の最新調査によると、世界の免疫療法薬市場規模は2034年までに1兆1,520億3,000万米ドルに達する見込みです。同レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

免疫療法薬市場は、特定の細胞や経路を標的とすることで、体内の免疫系を利用して疾患、特にがんを治療する医薬品の開発、生産、販売を含みます。従来の治療法よりも標的治療の採用が増加していることが、免疫療法薬市場の成長を大きく後押ししています。モノクローナル抗体などの標的療法は、がん細胞や病原体を特異的に攻撃するように設計されているため、健康な細胞へのダメージが最小限に抑えられ、化学療法などの従来の治療によく見られる副作用も軽減されます。より精密で効果的な治療へのシフトは、遺伝子や疾患の特徴に基づいて個々の患者のプロファイルに合わせた治療を行う個別化医療への需要の高まりと一致しています。その結果、免疫療法薬市場の需要は予測期間中に拡大すると予測されています。

新たな免疫療法薬の承認と用途の拡大が、市場の成長をさらに後押ししています。例えば、2024年4月、アストラゼネカと第一三共のEnhertuは、前治療歴のある転移性HER2陽性固形がんに対する初の腫瘍診断的HER2指向性治療薬としてFDAから承認され、標的免疫療法ソリューションへの動向を例証しています。

このような進歩は治療効果を高めるとともに、腫瘍学やその他の治療領域において免疫療法が標準治療の選択肢として広く受け入れられることにも貢献しています。様々ながんを含む慢性疾患の蔓延は、これらの革新的な治療法に対する需要をさらに高め、免疫療法薬市場の拡大を確固たるものにすると予想されます。

近年、ヘルスケア機関や支援団体に支えられた認知度の向上と疾患の早期発見が、タイムリーな治療を促すことで免疫療法薬市場を大きく活性化しています。このような積極的なアプローチにより、免疫療法による治療成績の向上が期待されています。さらに、共同研究や研究開発への多額の投資によるバイオテクノロジーの進歩が、免疫療法ソリューションの革新を促進しています。これらにより、治療の選択肢が拡大し、患者の治療が向上することで、市場の成長が促進されています。

免疫療法薬市場レポートハイライト

抗体医薬は、がんや自己免疫疾患の治療において、標的を絞った精密な治療効果が実証されていることから、免疫療法薬市場を独占しています。

がん領域は免疫療法薬市場で最大のシェアを占めており、アンメット・メディカル・ニーズの高さと新治療法の有望な成果により、今後も優位性を保つと予測されています。

北米地域は、がん罹患率の高さ、強固なヘルスケアシステム、バイオテクノロジーへの多額の投資、新治療法の急速な導入などにより、2024年の同市場で最大の売上シェアを占めました。

アジア太平洋地域の免疫療法薬市場は、ヘルスケアインフラの進歩、高い疾病罹患率、臨床試験と研究の強力なパイプラインにより、最も急速な成長が見込まれています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の免疫療法薬市場の洞察

• 市場スナップショット
• 免疫療法薬市場力学
  • 促進要因と機会
    • 免疫療法の研究開発活動の進歩
    • 免疫療法における併用療法が市場の成長を牽引
  • 抑制要因と課題
    • 規制上のハードルと承認の遅れ
• PESTEL分析
• 免疫療法薬市場の応用動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の免疫療法薬市場：タイプ別

• 主な調査結果
• イントロダクション
• 抗体医薬品
• 阻害薬
• インターフェロンとインターロイキン
• ワクチン
• その他

第6章 世界の免疫療法薬市場：用途別

• 主な調査結果
• イントロダクション
• がん
• 自己免疫疾患および炎症性疾患
• 血液学
• 骨学
• 神経学
• その他

第7章 世界の免疫療法薬市場：投与経路別

• 主な調査結果
• イントロダクション
• 静脈内
• 皮下
• 経口
• その他

第8章 世界の免疫療法薬市場：エンドユーザー別

• 主な調査結果
• イントロダクション
• 病院
• 長期介護施設
• その他

第9章 世界の免疫療法薬市場：地域別

• 主な調査結果
• イントロダクション
  • 免疫療法薬市場の評価：地域別、2020-2034年
• 北米
  • 北米：タイプ別、2020-2034年
  • 北米：投与経路別、2020-2034年
  • 北米：用途別、2020-2034年
  • 北米：エンドユーザー別、2020-2034年
  • 米国
  • カナダ
• 欧州
  • 欧州：タイプ別、2020-2034年
  • 欧州：投与経路別、2020-2034年
  • 欧州：用途別、2020-2034年
  • 欧州：エンドユーザー別、2020-2034年
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋地域：タイプ別、2020-2034年
  • アジア太平洋地域：投与経路別、2020-2034年
  • アジア太平洋地域：用途別、2020-2034年
  • アジア太平洋地域：エンドユーザー別、2020-2034年
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ
  • 中東・アフリカ：タイプ別、2020-2034年
  • 中東・アフリカ：投与経路別、2020-2034年
  • 中東・アフリカ：用途別、2020-2034年
  • 中東・アフリカ：エンドユーザー別、2020-2034年
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ
• ラテンアメリカ
  • ラテンアメリカ：タイプ別、2020-2034年
  • ラテンアメリカ：投与経路別、2020-2034年
  • ラテンアメリカ：用途別、2020-2034年
  • ラテンアメリカ：エンドユーザー別、2020-2034年
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• 提携/協業/合意/公開

第11章 企業プロファイル

• Abbvie Inc.
• Amgen Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• F. Hoffman-La Roche Ltd.
• Gilead Sciences, Inc.
• GSK PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.

List of Tables:

Table 1 Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 2 Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 3 Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 4 Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 5 North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 7 North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 8 North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 9 U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 11 U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 12 U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 13 Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 15 Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 16 Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 17 Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 19 Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 20 Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 21 UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 23 UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 24 UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 25 France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 26 France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 27 France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 28 France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 29 Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 31 Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 32 Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 33 Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 35 Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 36 Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 37 Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 39 Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 40 Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 41 Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 43 Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 44 Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 45 Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 47 Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 48 Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 51 Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 52 Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 55 Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 56 Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 57 China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 58 China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 59 China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 60 China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 61 India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 62 India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 63 India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 64 India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 65 Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 67 Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 68 Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 69 Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 71 Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 72 Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 73 Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 75 Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 76 Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 77 South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 79 South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 80 South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 81 Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 83 Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 84 Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 97 UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 99 UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 100 UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 101 Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 103 Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 104 Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 105 South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 107 South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 108 South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 113 Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 115 Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 116 Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 117 Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 119 Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 120 Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 121 Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 123 Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 124 Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 125 Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 127 Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 128 Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Immunotherapy Drugs Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global Immunotherapy Drugs Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Route of Administration

Figure 9. Global Immunotherapy Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)

Figure 10. Market by Application

Figure 11. Global Immunotherapy Drugs Market, by Application, 2024 & 2034 (USD Billion)

Figure 12. Market by End-User

Figure 13. Global Immunotherapy Drugs Market, by End-User, 2024 & 2034 (USD Billion)

The global immunotherapy drugs market size is expected to reach USD 1,152.03 billion by 2034, according to a new study by Polaris Market Research. The report "Immunotherapy Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Antibody Drugs, Inhibitor Drugs, Interferons and Interleukins, Vaccines, and Others), Application, Route of Administration, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The immunotherapy drugs market involves the development, production, and sale of medications that use the body's immune system to treat diseases, particularly cancer, by targeting specific cells or pathways. The rising adoption of targeted therapy over traditional treatment methods is significantly driving the immunotherapy drugs market growth. Targeted therapies, such as monoclonal antibodies, are designed to specifically attack cancer cells or pathogens, which minimizes damage to healthy cells and reduces side effects commonly associated with conventional treatments such as chemotherapy. This shift towards more precise and effective treatments aligns with the increasing demand for personalized medicine, which tailors therapies to individual patient profiles based on genetic and disease characteristics. As a result, the immunotherapy drugs market demand is projected to grow over the forecast period.

The approval of new immunotherapy drugs and the expansion of their applications are further propelling market growth. For instance, in April 2024, AstraZeneca and Daiichi Sankyo's Enhertu were approved by the FDA as the first tumor-agnostic HER2-directed therapy for previously treated metastatic HER2-positive solid tumors, exemplifying the trend toward targeted immunotherapy solutions.

These advancements enhance treatment efficacy and also contribute to a broader acceptance of immunotherapy as a standard care option in oncology and other therapeutic areas. The growing prevalence of chronic diseases, including various cancers, is expected to increase the demand for these innovative therapies further, solidifying the immunotherapy drugs market expansion.

In recent years, increasing awareness and earlier detection of diseases, supported by healthcare organizations and advocacy groups, have significantly enhanced the immunotherapy drugs market by encouraging timely treatment. This proactive approach allows for better outcomes with immunotherapies. Further, advancements in biotechnology driven by research collaborations and substantial investments in R&D are fostering innovation in immunotherapy solutions. Together, these are expanding treatment options and improving patient care, thereby propelling market growth.

Immunotherapy Drugs Market Report Highlights

The antibody drugs segment dominated the immunotherapy drugs market due to their proven efficacy in treating cancers and autoimmune diseases with targeted precision.

The cancer segment held the largest immunotherapy drugs market share and is expected to remain dominant due to high unmet medical needs and the promising results of new therapies.

North America region held the largest revenue share of the market in 2024 due to high cancer prevalence, a robust healthcare system, significant investments in biotechnology, and rapid adoption of new therapies.

The immunotherapy drugs market in Asia Pacific is expected to grow fastest due to advancements in healthcare infrastructure, high disease incidence, and a strong pipeline of clinical trials and research.

The global key market players include Abbvie Inc.; Amgen Inc.; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffman-La Roche Ltd.; Gilead Sciences, Inc.; GSK PLC; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and others.

Polaris Market Research has segmented the immunotherapy drugs market report based on type, application, route of administration, end user, and region:

By Type Outlook

§ Antibody Drugs

§ Inhibitor Drugs

§ Interferons and Interleukins

§ Vaccines

§ Others

By Application Outlook

§ Cancer

§ Autoimmune and Inflammatory Diseases

§ Hematology

§ Osteology

§ Neurology

§ Others

By Route of Administration Outlook

§ Intravenous

§ Subcutaneous

§ Oral

§ Others

By End User Outlook

§ Hospitals

§ Long-Term Care Facilities

§ Others

By Regional Outlook

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Immunotherapy Drugs Market Insights

• 4.1. Immunotherapy Drugs Market - Market Snapshot
• 4.2. Immunotherapy Drugs Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Advancements in Immunotherapy Research & Development Activities
    • 4.2.1.2. Combination Therapies in Immunotherapy Drives Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Regulatory Hurdles and Approval Delays
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Immunotherapy Drugs Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Immunotherapy Drugs Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
• 5.3. Antibody Drugs
  • 5.3.1. Global Immunotherapy Drugs Market, by Antibody Drugs, by Region, 2020-2034 (USD Billion)
• 5.4. Inhibitor Drugs
  • 5.4.1. Global Immunotherapy Drugs Market, by Inhibitor Drugs, by Region, 2020-2034 (USD Billion)
• 5.5. Interferons and Interleukins
  • 5.5.1. Global Immunotherapy Drugs Market, by Interferons and Interleukins, by Region, 2020-2034 (USD Billion)
• 5.6. Vaccines
  • 5.6.1. Global Immunotherapy Drugs Market, by Vaccines, by Region, 2020-2034 (USD Billion)
• 5.7. Other
  • 5.7.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Immunotherapy Drugs Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global Immunotherapy Drugs Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Autoimmune and Inflammatory Diseases
  • 6.4.1. Global Immunotherapy Drugs Market, by Autoimmune and Inflammatory Diseases, by Region, 2020-2034 (USD Billion)
• 6.5. Hematology
  • 6.5.1. Global Immunotherapy Drugs Market, by Hematology, by Region, 2020-2034 (USD Billion)
• 6.6. Osteology
  • 6.6.1. Global Immunotherapy Drugs Market, by Osteology, by Region, 2020-2034 (USD Billion)
• 6.7. Neurology
  • 6.7.1. Global Immunotherapy Drugs Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 6.8. Other
  • 6.8.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Immunotherapy Drugs Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Intravenous
  • 7.3.1. Global Immunotherapy Drugs Market, by Intravenous, by Region, 2020-2034 (USD Billion)
• 7.4. Subcutaneous
  • 7.4.1. Global Immunotherapy Drugs Market, by Subcutaneous, by Region, 2020-2034 (USD Billion)
• 7.5. Oral
  • 7.5.1. Global Immunotherapy Drugs Market, by Oral, by Region, 2020-2034 (USD Billion)
• 7.6. Other
  • 7.6.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

8. Global Immunotherapy Drugs Market, by End-User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 8.3. Hospitals
  • 8.3.1. Global Immunotherapy Drugs Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.4. Long-Term Care Facilities
  • 8.4.1. Global Immunotherapy Drugs Market, by Long-Term Care Facilities, by Region, 2020-2034 (USD Billion)
• 8.5. Other
  • 8.5.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Immunotherapy Drugs Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Immunotherapy Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Immunotherapy Drugs Market - North America
  • 9.3.1. North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.3. North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.5. Immunotherapy Drugs Market - U.S.
    • 9.3.5.1. U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.6. Immunotherapy Drugs Market - Canada
    • 9.3.6.1. Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.4. Immunotherapy Drugs Market - Europe
  • 9.4.1. Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.5. Immunotherapy Drugs Market - UK
    • 9.4.5.1. UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.6. Immunotherapy Drugs Market - France
    • 9.4.6.1. France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.7. Immunotherapy Drugs Market - Germany
    • 9.4.7.1. Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.8. Immunotherapy Drugs Market - Italy
    • 9.4.8.1. Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.9. Immunotherapy Drugs Market - Spain
    • 9.4.9.1. Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.10. Immunotherapy Drugs Market - Netherlands
    • 9.4.10.1. Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.11. Immunotherapy Drugs Market - Russia
    • 9.4.11.1. Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.12. Immunotherapy Drugs Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.5. Immunotherapy Drugs Market - Asia Pacific
  • 9.5.1. Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.5. Immunotherapy Drugs Market - China
    • 9.5.5.1. China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.6. Immunotherapy Drugs Market - India
    • 9.5.6.1. India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.7. Immunotherapy Drugs Market - Malaysia
    • 9.5.7.1. Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.8. Immunotherapy Drugs Market - Japan
    • 9.5.8.1. Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.9. Immunotherapy Drugs Market - Indonesia
    • 9.5.9.1. Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.10. Immunotherapy Drugs Market - South Korea
    • 9.5.10.1. South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.11. Immunotherapy Drugs Market - Australia
    • 9.5.11.1. Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.12. Immunotherapy Drugs Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.6. Immunotherapy Drugs Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.5. Immunotherapy Drugs Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.6. Immunotherapy Drugs Market - UAE
    • 9.6.6.1. UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.7. Immunotherapy Drugs Market - Israel
    • 9.6.7.1. Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.8. Immunotherapy Drugs Market - South Africa
    • 9.6.8.1. South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.9. Immunotherapy Drugs Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.7. Immunotherapy Drugs Market - Latin America
  • 9.7.1. Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.5. Immunotherapy Drugs Market - Mexico
    • 9.7.5.1. Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.6. Immunotherapy Drugs Market - Brazil
    • 9.7.6.1. Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.7. Immunotherapy Drugs Market - Argentina
    • 9.7.7.1. Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.8. Immunotherapy Drugs Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbvie Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Amgen Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. AstraZeneca
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bristol-Myers Squibb Company
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. F. Hoffman-La Roche Ltd.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Gilead Sciences, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GSK PLC
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Johnson & Johnson Services, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Merck & Co., Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Novartis AG
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Pfizer Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Sanofi
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Takeda Pharmaceutical Company Limited.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Teva Pharmaceutical Industries Ltd.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development